Sio Capital Management Decreased Its Koninklijke Philips Nv (Call) (PHG) Stake; Shorts at Aethlon Medical (AEMD) Lowered By 4.73%

August 26, 2017 - By Adrian Mccoy

Aethlon Medical Incorporated (NASDAQ:AEMD) had a decrease of 4.73% in short interest. AEMD’s SI was 151,200 shares in August as released by FINRA. Its down 4.73% from 158,700 shares previously. With 15,000 avg volume, 10 days are for Aethlon Medical Incorporated (NASDAQ:AEMD)’s short sellers to cover AEMD’s short positions. The SI to Aethlon Medical Incorporated’s float is 2.05%. The stock increased 1.40% or $0.02 on August 25, reaching $1.45. About 24,980 shares traded. Aethlon Medical, Inc. (NASDAQ:AEMD) has declined 56.57% since August 26, 2016 and is downtrending. It has underperformed by 73.27% the S&P500.

Sio Capital Management Llc decreased Koninklijke Philips Nv (Call) (PHG) stake by 78.39% reported in 2016Q4 SEC filing. Sio Capital Management Llc sold 362,662 shares as Koninklijke Philips Nv (Call) (PHG)’s stock rose 20.05%. The Sio Capital Management Llc holds 100,000 shares with $3.06 million value, down from 462,662 last quarter. Koninklijke Philips Nv (Call) now has $36.26 billion valuation. The stock increased 1.11% or $0.42 on August 25, reaching $38.36. About 976,592 shares traded. Koninklijke Philips NV (ADR) (NYSE:PHG) has risen 38.13% since August 26, 2016 and is uptrending. It has outperformed by 21.43% the S&P500.

Aethlon Medical, Inc. is a medical device firm focused on creating devices for cancer, infectious disease and other life-threatening conditions. The company has market cap of $12.46 million. The Firm operates through two divisions: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. It currently has negative earnings. The Company’s lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression.

Among 13 analysts covering Koninklijke Philips N.V. (NYSE:PHG), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. Koninklijke Philips N.V. had 13 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Koninklijke Philips NV (ADR) (NYSE:PHG) earned “Buy” rating by UBS on Wednesday, August 10. Nomura upgraded the shares of PHG in report on Thursday, August 27 to “Neutral” rating. As per Tuesday, July 28, the company rating was upgraded by Societe Generale. The stock has “Hold” rating by ING Group on Friday, November 27. The stock of Koninklijke Philips NV (ADR) (NYSE:PHG) earned “Buy” rating by Citigroup on Wednesday, November 23. The company was upgraded on Wednesday, September 2 by RBC Capital Markets. Natixis downgraded Koninklijke Philips NV (ADR) (NYSE:PHG) on Wednesday, June 21 to “Neutral” rating. The firm has “Equal-Weight” rating by Morgan Stanley given on Monday, December 12. The stock has “Equal Weight” rating by Barclays Capital on Tuesday, July 28. On Wednesday, May 11 the stock rating was upgraded by BNP Paribas to “Outperform”.